#haematology #NICE #NHS #leukaemiaCART #Autolus #leukaemia #CARTtherapy #NHSroutinecommissioning #Aucatzyl #BcellALL #acutelymphoblasticleukaemia #relapsedALL #refractoryALL #Bcellprecursoracutelymphoblasticleukaemia #ALL #NICEfinaldraftguidance #HTA #FELIXtrial #NICEguidance
zurl.co/h6OwD
zurl.co/h6OwD
NICE backs NHS use of Autolus' leukaemia CAR-T
Hundreds of people with an aggressive leukaemia will be able to access a CAR-T therapy developed by UK biotech Autolus after a NICE recommendation.
pharmaphorum.com
December 4, 2025 at 9:39 AM